An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
7 auth.
Balázs Győrffy,
A. Lánczky,
A. Eklund,
C. Denkert,
J. Budczies,
Qiyuan Li,
...
Z. Szallasi
|
11 |
2010 |
11
2010
|
The Nottingham prognostic index in primary breast cancer
M. Galea,
R. Blamey,
C. Elston,
I. Ellis
|
9 |
2005 |
9
2005
|
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
M. Protani,
M. Coory,
Jennifer H Martin
|
9 |
2010 |
9
2010
|
Abstract
12 auth.
Simak Ali,
N. Sarwar,
Jie Jiang,
D. Peston,
H. Sinnett,
P. Madden,
...
Sami Shousha,
A. E. Lykkesfeldt,
J. Gee,
R. I. Nicholson,
Elena Kulinskaya,
R. C. Coombes
|
9 |
2006 |
9
2006
|
Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update
M. Lacroix,
G. Leclercq
|
9 |
2004 |
9
2004
|
A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses
24 auth.
D. Cameron,
M. Casey,
M. Press,
D. Lindquist,
T. Pieńkowski,
C. Romieu,
S. Chan,
A. Jagiełło-Gruszfeld,
B. Kaufman,
J. Crown,
...
A. Chan,
M. Campone,
P. Viens,
N. Davidson,
V. Gorbounova,
J. Raats,
D. Skarlos,
B. Newstat,
D. Roychowdhury,
P. Paoletti,
C. Oliva,
S. Rubin,
S. Stein,
C. Geyer
|
9 |
2008 |
9
2008
|
Epidemiology of basal-like breast cancer
16 auth.
R. Millikan,
B. Newman,
C. Tse,
P. Moorman,
K. Conway,
L. Dressler,
Lisa V. Smith,
M. Labbok,
J. Geradts,
J. Bensen,
...
S. Jackson,
S. Nyante,
C. Livasy,
L. Carey,
H. Earp,
C. Perou
|
9 |
2008 |
9
2008
|
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer
9 auth.
D. Hershman,
T. Shao,
L. Kushi,
D. Buono,
W. Tsai,
L. Fehrenbacher,
...
M. Kwan,
S. Gomez,
A. Neugut
|
9 |
2011 |
9
2011
|
miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
7 auth.
A. Lánczky,
Á. Nagy,
G. Bottai,
G. Munkácsy,
A. Szabó,
L. Santarpia,
...
Balázs Győrffy
|
9 |
2016 |
9
2016
|
Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial
19 auth.
Jane A. Cauley,
L. Norton,
Marc E. Lippman,
S. Eckert,
Kathryn A. Krueger,
David W. Purdie,
J. Farrerons,
A. Karasik,
D. Mellstrom,
Kong Wah Ng,
...
Jan J. Stepan,
T. J. Powles,
M. Morrow,
Alberto Costa,
S. Silfen,
E. Walls,
H. Schmitt,
D. Muchmore,
V. Craig Jordan
|
9 |
2004 |
9
2004
|
Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors
N. Weidner
|
9 |
2004 |
9
2004
|
Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu
8 auth.
C. Benz,
G. Scott,
J. Sarup,
Randolph M. Johnson,
D. Tripathy,
E. Coronado,
...
H. Shepard,
C. Osborne
|
9 |
1992 |
9
1992
|
Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review
C. Murphy,
L. K. Bartholomew,
Melissa Y. Carpentier,
S. Bluethmann,
S. Vernon
|
9 |
2012 |
9
2012
|
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
18 auth.
L. Dirix,
I. Takács,
G. Jerusalem,
P. Nikolinakos,
H. Arkenau,
A. Forero-Torres,
R. Boccia,
M. Lippman,
R. Somer,
M. Šmakal,
...
L. Emens,
B. Hrinczenko,
W. Edenfield,
J. Gurtler,
A. von Heydebreck,
H. Grote,
K. Chin,
E. Hamilton
|
9 |
2017 |
9
2017
|
The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen
18 auth.
M. Goetz,
S. Knox,
V. Suman,
J. Rae,
Stephanie L. Safgren,
M. Ames,
D. Visscher,
C. Reynolds,
F. Couch,
W. Lingle,
...
R. Weinshilboum,
E. B. Fritcher,
Andrea M Nibbe,
Z. Desta,
A. Nguyen,
D. Flockhart,
E. Perez,
J. Ingle
|
9 |
2006 |
9
2006
|
Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry
7 auth.
E. Inwald,
M. Klinkhammer-Schalke,
F. Hofstädter,
F. Zeman,
M. Koller,
M. Gerstenhauer,
...
O. Ortmann
|
9 |
2013 |
9
2013
|
Estrogen Receptor Breast Cancer Phenotypes in the Surveillance, Epidemiology, and End Results Database
W. Anderson,
N. Chatterjee,
W. Ershler,
O. Brawley
|
9 |
2002 |
9
2002
|
Pattern of metastatic spread in triple-negative breast cancer
R. Dent,
W. Hanna,
M. Trudeau,
E. Rawlinson,
P. Sun,
S. Narod
|
9 |
2009 |
9
2009
|
